Voyager Therapeutics, Inc.

VYGR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$71,367$68,802$98,959$117,433
Short-Term Investments$195,317$162,073$19,889$15,106
Receivables$4,491$84,455$639$748
Inventory$0$0$0$0
Other Curr. Assets$5,634$4,354$5,012$3,411
Total Curr. Assets$276,809$319,684$124,499$136,698
Property Plant & Equip (Net)$47,663$30,004$33,342$55,378
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$65,704$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$2,874$1,593$1,515$1,779
Total NC Assets$116,241$31,597$34,857$57,157
Other Assets$0$0$0$0
Total Assets$393,050$351,281$159,356$193,855
Liabilities
Payables$3,996$1,604$2,566$574
Short-Term Debt$7,227$3,200$2,832$5,571
Tax Payable$0$0$0$0
Deferred Revenue$24,394$42,881$59,377$33,886
Other Curr. Liab.$14,171$16,823$7,816$10,950
Total Curr. Liab.$49,788$64,508$72,591$50,981
LT Debt$36,499$17,094$20,294$38,608
Deferred Rev, NC$6,003$32,359$6,450$8,210
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,000$1,000$1,001$1,001
Total NC Liab.$43,502$50,453$27,745$47,819
Other Liabilities$0$0$0$0
Cap. Leases$43,726$20,294$23,126$44,179
Total Liabilities$93,290$114,961$100,336$98,800
Equity
Pref Stock$0$0$0$0
Common Stock$55$44$38$38
Retained Earnings-$326,184-$261,182-$393,512-$347,104
AOCI-$407-$48-$219-$138
Other Equity$626,296$497,506$452,713$442,259
Total Equity$299,760$236,320$59,020$95,055
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$393,050$351,281$159,356$193,855
Net Debt-$27,641-$48,508-$75,833-$73,254